STOCK TITAN

Waystar Holding (WAY) Stock Price, News & Analysis

WAY NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
27 252 sessions, November 20, 2025 to November 20, 2026
Largest daily move
-15.4% close of April 30, 2026
1-year change
-23.8% closing prices, November 20, 2025 to November 20, 2026
1-month change
-7.9% closing prices, October 20, 2026 to November 20, 2026

Company Description

Waystar Holding Corp. (Nasdaq: WAY) operates in the healthcare sector as a health information services and healthcare payment software company. According to the company’s public statements, Waystar provides mission-critical, cloud-native software that is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Its enterprise-grade platform focuses on transforming the complex processes that govern how healthcare providers are paid by payers and patients, from pre-service engagement through post-service remittance and reconciliation.

Waystar describes its software as mission-critical because it supports core financial and administrative workflows for healthcare organizations. The platform is designed to enhance data integrity, eliminate manual tasks, and improve claim and billing accuracy. By doing so, it aims to increase transparency, reduce labor costs, and support faster, more accurate reimbursement and cash flow for providers. The company’s solutions are used by a broad base of healthcare clients across the United States and U.S. territories.

Business focus and platform capabilities

Waystar’s enterprise-grade platform annually processes billions of healthcare payment transactions and a very large volume of gross claims. Company disclosures state that Waystar serves approximately 30,000 clients, representing over 1 million distinct providers. Its client base includes a significant portion of institutions on the U.S. News Best Hospitals list. Waystar’s platform spans a large share of U.S. patients and hospital discharges, underscoring the scale at which its technology is deployed in the healthcare payment ecosystem.

The company emphasizes that its platform unifies clinical, financial, and administrative intelligence. Through this integrated data network, Waystar seeks to support more accurate claims, reduce preventable denials, and improve the overall efficiency of the revenue cycle. The platform is cloud-based and is described as cloud-native, which reflects its design for modern, scalable deployment across healthcare organizations of varying sizes.

AI and AltitudeAI™

A central element of Waystar’s strategy is the use of artificial intelligence in healthcare payments. Waystar has introduced Waystar AltitudeAI™, which the company characterizes as an AI-powered capability on its platform. Public communications state that AltitudeAI has been used to prevent a substantial amount of claim denials and to deliver significant time savings in denial prevention and recovery workflows. The company reports that AltitudeAI has supported denial appeals and prevention, helping providers overturn more denials and reduce manual work associated with claim management.

Waystar has also announced the introduction of agentic intelligence on its cloud-native platform as part of its vision for an autonomous revenue cycle. According to the company, this agentic AI operates as a dynamic, end-to-end network that acts within workflows, executes defined tasks, and learns from outcomes with minimal intervention. Waystar states that this approach is fueled by proprietary data from billions of annual transactions and a large share of U.S. hospital discharges, and is intended to help eliminate friction in healthcare payments by activating the right AI at the right time.

Revenue cycle and denial management focus

Waystar’s public materials highlight a focus on the healthcare revenue cycle, particularly around denial prevention, reimbursement recovery, and clinical documentation integrity. The company describes capabilities that aim to:

  • Prevent denials through integrated documentation, coding, and charge capture revenue protection.
  • Recommend corrections automatically based on historical denial insights to create clean, accurate, and compliant claims.
  • Accelerate recovery through intelligence-powered clinical appeals.
  • Support clinical documentation integrity workflows by analyzing medical records and pre-populating correction requests with supporting clinical context.

These capabilities are presented as ways to reduce administrative burden, improve the accuracy of reimbursement, and allow clinical and administrative staff to focus on higher-value work. Waystar has also discussed pre-service cost estimation and digital patient financial engagement as part of addressing uncompensated care and patient collections, describing improvements in pre-service payment behavior among early adopters of its technology.

Data scale and client base

Waystar’s disclosures emphasize the scale of its data and client relationships as a differentiating factor. The company reports that its platform processes more than 6 billion healthcare payment transactions annually and over $1.8 trillion in annual gross claims in some of its public communications, and more than 7.5 billion annual transactions and over $2.4 trillion in annual gross claims in later statements. It also notes that its network spans a large percentage of U.S. patients and a substantial share of U.S. hospital discharges. Waystar states that it serves more than one million providers and tens of thousands of client organizations, including many prominent hospitals and health systems.

Waystar’s client base includes hospitals, health systems, and other healthcare providers that rely on its software to manage payment workflows. The company has highlighted that its solutions are used by a large portion of institutions recognized on national hospital rankings, which it presents as evidence of adoption among complex, high-acuity care providers.

Corporate and market context

Waystar Holding Corp. is listed on Nasdaq under the ticker symbol WAY. The company has described itself as an emerging growth company in SEC filings. It has also disclosed that it became a member of the S&P SmallCap 600® Index, which is produced by S&P Dow Jones Indices and is intended to reflect the performance of U.S. equities at the scale of companies like Waystar. Inclusion in this index is presented by the company as a reflection of its growth and visibility in public markets.

Waystar operates in a highly regulated healthcare environment and references compliance with healthcare laws, data privacy and security regulations, and financial transaction rules in its public filings. The company also discusses its use of credit facilities and amendments to its credit agreements to support its capital structure and strategic initiatives, as detailed in multiple Form 8-K filings.

Acquisition of Iodine Software

Waystar has disclosed that it entered into and completed an acquisition of Iodine Software Holdings, Inc. Through a sequence of mergers, Waystar acquired Iodine using a combination of cash consideration and shares of Waystar common stock issued to certain Iodine equityholders. The company describes Iodine as contributing one of the largest clinical datasets in the industry, and states that combining Iodine’s clinical intelligence with Waystar’s financial data strengthens its AI platform.

According to Waystar’s public statements, Iodine’s client base of more than 1,000 hospitals and health systems expands Waystar’s total addressable market and creates cross-selling opportunities. The company emphasizes that uniting expertise in the stage between care delivery and claim submission provides expansive visibility across the healthcare payment ecosystem and fuels next-generation AI capabilities aimed at preventing revenue leakage and ensuring providers are paid fully and accurately.

Geographic reach

Waystar states that the market for its solutions extends throughout the United States, including Puerto Rico and other U.S. territories. The company’s press releases reference operations and corporate presence in locations such as Lehi, Utah, and Louisville, Kentucky, indicating a footprint that supports its national client base.

Risk, regulation, and disclosures

In its SEC filings and press releases, Waystar discusses a range of factors that can affect its business, including competition in healthcare technology, the need to retain and attract clients, the importance of strategic relationships, and the impact of healthcare transaction volumes. The company also highlights regulatory and legal considerations, including healthcare laws, data privacy and security regulations, and consumer protection rules. These disclosures are intended to inform investors about risks and uncertainties that may cause actual results to differ from forward-looking statements.

Stock Performance

$26.52
-2.10%
-0.57
Last updated: at
-23.8%
Performance 1 year
192.4M
Shares outstanding As of October 26, 2026.

Waystar Holding (WAY) closed at $26.52 on November 20, 2026. Over the past 12 months, the price has lost 23.8%.

See what a $1,000 investment in WAY would be worth today

Average down calculator for WAY

WAY Metrics & Rankings

Price returns through November 20, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Insider Radar

Net Sellers
90-Day Summary
0
Shares Bought
247,500
Shares Sold
3
Transactions
Most Recent Transaction
Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares @ $28.75 on November 10, 2026

Insider selling at Waystar Holding over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

Waystar Holding generated $1.1B in revenue in FY2025, retaining a 68.3% gross margin, operating income reached $249.3M (22.7% operating margin), and net income was $112.1M, reflecting a 10.2% net profit margin. Diluted earnings per share stood at $0.61. The company generated $309.7M in operating cash flow. The current ratio was 1.41, measuring current assets divided by current liabilities.

$1.1B
Revenue (FY2025)
$112.1M
Net Income (FY2025)
$309.7M
Operating Cash Flow

Upcoming Events

JUN
15
June 15, 2027 Corporate

Advisor term end

Steve Oreskovich will remain Waystar advisor through 2027-06-15 to support the CFO transition; role ends that day.

Waystar Holding has 1 upcoming scheduled event. The next event, "Advisor term end", is scheduled for June 15, 2027 (in 205 days). Investors can track these dates to stay informed about potential catalysts that may affect the WAY stock price.

Short Interest History

Last 12 Months

Short interest in Waystar Holding (WAY) currently stands at 15.0 million shares, down 3.3% from the previous reporting period, representing 10.8% of the float. Since November 2025, short interest has increased by 77.5%.

Days to Cover History

Last 12 Months

Days to cover for Waystar Holding (WAY) currently stands at 8.4 days, up 18.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 38.2%. Across the settlements charted above, it has ranged from 2.5 to 8.4 days.

WAY Company Profile & Sector Positioning

Waystar Holding (WAY) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing WAY often look at related companies in the same sector, including Doximity, Inc. (DOCS), Heartflow, Inc. (HTFL), Privia Health Group, Inc. (PRVA), HealthEquity, Inc (HQY), and Hinge Health, Inc. (HNGE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate WAY's relative position within its industry.

Frequently Asked Questions

The current stock price of Waystar Holding (WAY) is $26.52 as of November 20, 2026.

The market cap of Waystar Holding (WAY) is approximately $5.1B. Learn more about what market capitalization means .

The FY2025 revenue of Waystar Holding (WAY) is $1.1B, from its most recent completed fiscal year.

The FY2025 net income of Waystar Holding (WAY) is $112.1M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Waystar Holding (WAY) is $0.61 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Waystar Holding (WAY) is $309.7M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Waystar Holding (WAY) is 10.2% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Waystar Holding (WAY) is 22.7% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Waystar Holding (WAY) is 68.3% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Waystar Holding (WAY), current assets divided by current liabilities, was 1.41 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Waystar Holding (WAY) is $751.1M for FY2025, its most recent completed fiscal year.

The operating income of Waystar Holding (WAY) is $249.3M for FY2025, its most recent completed fiscal year. Learn about operating income.

Waystar Holding Corp. provides mission-critical, cloud-native healthcare payment software. Its enterprise-grade platform is designed to simplify healthcare payments for providers by enhancing data integrity, reducing manual tasks, and improving claim and billing accuracy from pre-service engagement through post-service remittance and reconciliation.

Waystar operates in the health information services industry within the broader healthcare sector. The company focuses on software that supports healthcare payment workflows and revenue cycle processes for providers.

Waystar describes its platform as AI-powered and highlights Waystar AltitudeAI™ as a key capability. According to the company, AltitudeAI helps prevent claim denials, accelerates denial appeals and reimbursement recovery, and delivers significant time savings by automating parts of the revenue cycle. Waystar has also introduced agentic intelligence to support an autonomous revenue cycle with AI agents that act within workflows and learn from outcomes.

Waystar states that it serves approximately 30,000 clients, representing over 1 million distinct providers. Its client base includes hospitals, health systems, and other healthcare providers, including a large portion of institutions listed on the U.S. News Best Hospitals list.

Waystar AltitudeAI™ is the company’s AI capability integrated into its healthcare payment software platform. Public statements indicate that AltitudeAI is used for denial prevention, denial appeals, and reimbursement recovery, helping providers reduce manual work, overturn more denials, and improve financial outcomes.

Waystar uses the term agentic intelligence to describe AI agents on its platform that operate dynamically across workflows, execute defined tasks, and learn from outcomes with minimal human intervention. The company presents this as a step toward an autonomous revenue cycle, where AI-driven workflows help reduce administrative burden and improve the accuracy and speed of reimbursement.

Waystar reports that its platform processes billions of healthcare payment transactions annually and over a trillion dollars in gross claims each year. In its public communications, the company notes that its data network spans a large share of U.S. patients and a significant portion of U.S. hospital discharges, and unifies clinical, financial, and administrative intelligence at scale.

Waystar completed the acquisition of Iodine Software Holdings, Inc. through a series of mergers. The company states that Iodine contributes one of the largest clinical datasets in the industry. By combining Iodine’s clinical intelligence with Waystar’s financial data, Waystar aims to strengthen its AI platform, expand its total addressable market, and enhance its ability to prevent revenue leakage and support accurate provider reimbursement.

Waystar states that the market for its solutions extends throughout the United States and includes Puerto Rico and other U.S. territories. Its press releases reference operations in locations such as Lehi, Utah, and Louisville, Kentucky, supporting a nationwide client base.

Yes. Waystar has announced that it joined the S&P SmallCap 600® Index. The company presents this inclusion as recognition of its scale and growth within the U.S. equity markets.

In its SEC filings and public statements, Waystar notes that it operates in a heavily regulated industry and references healthcare laws, data privacy and security regulations, and financial transaction rules. The company discusses these areas as factors that can affect its operations and as part of the risk disclosures provided to investors.